Related Experiment Video
Updated: Aug 10, 2026
10:45
The Mouse Stroke Unit Protocol with Standardized Neurological Scoring for Translational Mouse Stroke Studies
Published on: February 7, 2025
Bench to bedside: the quest for quality in experimental stroke research
1Department of Experimental Neurology, Center for Stroke Research, Humboldt-Universität Berlin, Universitätsklinikum Charite, Berlin, Germany. ulrich.dirnagl@charite.de
Summary
Improving preclinical stroke research quality is crucial for successful clinical trials. Addressing issues like low statistical power and lack of blinding can enhance reproducibility and the translation of findings from bench to bedside.
Area of Science:
- Neuroscience
- Translational Medicine
Background:
- Significant progress in stroke research has not translated to successful clinical trials for neuroprotective agents.
- Systematic reviews reveal critical quality deficits in preclinical stroke research, impacting generalizability to other animal models of disease.
Purpose of the Study:
- To review quality-related sources of bias in experimental stroke research.
- To identify weaknesses such as low statistical power, inadequate statistical analysis, lack of blinding and randomization, and reporting deficiencies.
Main Methods:
- Review of existing literature and systematic reviews on preclinical stroke research quality.
- Discussion of common biases including statistical power, analysis defects, blinding, randomization, quality control, reporting, and publication bias.
Main Results:
- Identified key weaknesses in experimental stroke research that compromise reproducibility.
- Highlighted issues applicable to basic research and potentially other animal models of disease.
- Included quality-related biases not yet systematically studied but relevant to stroke research.
Conclusions:
- Implementing simple measures can improve the reproducibility of experimental results in stroke research.
- Enhancing preclinical research quality is essential for successful translation from bench to bedside.
- Future successful Phase III stroke trials depend on basic research adhering to improved quality criteria.